vimarsana.com

Latest Breaking News On - Anette lindqvist - Page 1 : vimarsana.com

Xbrane Biopharma : Invitation to presentation of Xbrane Biopharma s interim report January - March 2024 on May 16, 2024

Xbrane Biopharma : Invitation to presentation of Xbrane Biopharma s interim report January - March 2024 on May 16, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Anette lindqvistXbrane biopharmaXbrane biopharmasCompany news systemNasdaq stockholm

MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2023

/PRNewswire/ "The clinical efficacy of fostrox in combination with Lenvima continues to improve with median time to progression having increased to over 6.

San franciscoUnited statesJens lindbergAnette lindqvistKarl tobiesonUli hacksellAnders hallbergRichard torgersonMagnus christensenAsco gi congress onNomination committeeBoard memberNordea investment fundsHealthinvest partnersHallberg managementJanuary tango therapeutics

MEDIVIR AB - INTERIM REPORT JANUARY - SEPTEMBER 2023

MEDIVIR AB - INTERIM REPORT JANUARY - SEPTEMBER 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesComunidad autonoma de catalunaAnette lindqvistRichard torgersonUli hacksellJens lindbergMagnus christensenKarl tobiesonAnders hallbergScientific councilMedivir scientific advisory councilNational comprehensive cancer networkNomination committeeScientific advisory councilTango therapeuticsBoard member

Change in Medivir s Board of Directors

/PRNewswire/ Medivir AB (Nasdaq: MVIR) and (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of.

Uli hacksellAnette lindqvistNasdaq stockholmSmall capHealth care amp hospitalsMedical pharmaceuticalsPersonnel announcements

Invitation to presentation of Xbrane Biopharma s interim report January – March 2023 on May 31, 2023

Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Wednesday, May 31th, 2023, at 11.00 a.m. CET. Xbrane will publish the company’s interim report January. | May 29, 2023

Anette lindqvistXbrane biopharma ab publ stock exchangePress releaseEport xbrane se0007789409

vimarsana © 2020. All Rights Reserved.